SMARCA4-DEFICIENT PRIMARY CNS MALIGNANT TUMORS

Clinical trials for SMARCA4-DEFICIENT PRIMARY CNS MALIGNANT TUMORS explained in plain language.

Never miss a new study

Get alerted when new SMARCA4-DEFICIENT PRIMARY CNS MALIGNANT TUMORS trials appear

Sign up with your email to follow new studies for SMARCA4-DEFICIENT PRIMARY CNS MALIGNANT TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with aggressive, rare cancers

Disease control Recruiting now

This study is testing whether three drugs given together can treat rare and aggressive childhood cancers caused by missing specific proteins. It will first find the safest dose and then see if the combination effectively controls these difficult tumors. The trial is for children …

Matched conditions: SMARCA4-DEFICIENT PRIMARY CNS MALIGNANT TUMORS

Phase: PHASE1, PHASE2 • Sponsor: Susan Chi, MD • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

SMARCA4-DEFICIENT PRIMARY CNS MALIGNANT TUMORS

Get alerted when new SMARCA4-DEFICIENT PRIMARY CNS MALIGNANT TUMORS trials appear

New hope for kids with aggressive, rare cancers